- Home
- PLUG vs NEO Comparison
PLUG vs NEO Comparison
Compare PLUG & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- NEO
- Stock Information
- Founded
- PLUG 1997
- NEO 2001
- Country
- PLUG United States
- NEO United States
- Employees
- PLUG N/A
- NEO N/A
- Industry
- PLUG Industrial Machinery/Components
- NEO Precision Instruments
- Sector
- PLUG Energy
- NEO Health Care
- Exchange
- PLUG Nasdaq
- NEO Nasdaq
- Market Cap
- PLUG 1.0B
- NEO 1.2B
- IPO Year
- PLUG 1999
- NEO 1999
- Fundamental
- Price
- PLUG $0.86
- NEO $8.05
- Analyst Decision
- PLUG Hold
- NEO Buy
- Analyst Count
- PLUG 17
- NEO 9
- Target Price
- PLUG $2.19
- NEO $13.31
- AVG Volume (30 Days)
- PLUG 109.5M
- NEO 3.1M
- Earning Date
- PLUG 05-12-2025
- NEO 04-29-2025
- Dividend Yield
- PLUG N/A
- NEO N/A
- EPS Growth
- PLUG N/A
- NEO N/A
- EPS
- PLUG N/A
- NEO N/A
- Revenue
- PLUG $628,814,000.00
- NEO $672,361,000.00
- Revenue This Year
- PLUG $26.39
- NEO $13.05
- Revenue Next Year
- PLUG $25.44
- NEO $11.18
- P/E Ratio
- PLUG N/A
- NEO N/A
- Revenue Growth
- PLUG N/A
- NEO 10.10
- 52 Week Low
- PLUG $0.76
- NEO $6.08
- 52 Week High
- PLUG $4.90
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- PLUG 39.64
- NEO 43.34
- Support Level
- PLUG $0.76
- NEO $7.66
- Resistance Level
- PLUG $1.19
- NEO $8.31
- Average True Range (ATR)
- PLUG 0.08
- NEO 0.76
- MACD
- PLUG 0.02
- NEO -0.02
- Stochastic Oscillator
- PLUG 23.37
- NEO 44.47
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.